How are energy investors positioned?
Lifeward Ltd. (NASDAQ:LFWD), a leader in orthopedic and surgical appliances, announced significant changes to its Board of Directors today. The company has appointed Mark Grant as a Class II director, effective immediately. This appointment expands the board from seven to eight members. Grant, who recently became the company’s President and Co-Chief Executive Officer on June 2, will serve until the next Annual General Meeting of Shareholders on August 1, 2025.
In conjunction with Grant’s appointment, Larry Jasinski, a board member and Co-Chief Executive Officer, has informed the board of his decision to resign. His resignation is effective June 30, 2025, and is not due to any disagreements with the company’s operations, policies, or practices. Following his resignation, Jasinski will continue to serve in an advisory capacity through the end of the year.
The company also announced the date for its Annual Meeting, which is set for August 1, 2025. Shareholders interested in submitting proposals for the meeting must send them to the company’s Chief Financial Officer at the principal executive offices by June 23, 2025. These proposals must adhere to the rules of the Securities and Exchange Commission and the company’s Articles of Association.
The board’s decision to appoint Grant and the announcement of Jasinski’s departure come at a time of transition for Lifeward Ltd. The company emphasized that there are no disagreements or undisclosed material transactions involving Grant that prompted the changes. Grant will not receive additional compensation for his role as a board member due to his status as an employee director.
This report is based on a press release statement and provides a factual account of Lifeward Ltd.’s board changes and upcoming Annual General Meeting without speculation or promotional commentary.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.